MeSH Browser

MeSH Heading: Myasthenia Gravis, Autoimmune, Experimental
Tree Number(s): C10.114.656.300; C10.114.703.350; C10.668.758.725.300; C20.111.258.500.300; C20.111.258.625.350; E05.598.500.500.750
Unique ID: D020720
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D020720
Scope Note: Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)
Entry Term(s): Autoimmune Experimental Myasthenia Gravis; Experimental Autoimmune Myasthenia Gravis, Passive Transfer; Experimental Myasthenia; Experimental Myasthenia Gravis; Myasthenia Gravis, Autoimmune Experimental; Myasthenia Gravis, Experimental Autoimmune; Passive Transfer Experimental Autoimmune Myasthenia Gravis
Previous Indexing: Autoimmune Diseases (1969-1999); Myasthenia Gravis (1968-1999)
Public MeSH Note: 2005; see MYASTHENIA GRAVIS, EXPERIMENTAL AUTOIMMUNE 2000-2004
History Note: 2005 (2000)
Date Established: 2000/01/01
Date of Entry: 1999/11/05
Revision Date: 2019/02/22

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Nervous System Diseases [C10]
- Autoimmune Diseases of the Nervous System [C10.114]
  - Myasthenia Gravis [C10.114.656]

Nervous System Diseases [C10]
- Autoimmune Diseases of the Nervous System [C10.114]
  - Nervous System Autoimmune Disease, Experimental [C10.114.703]

Nervous System Diseases [C10]
- Neuromuscular Diseases [C10.668]
  - Neuromuscular Junction Diseases [C10.668.758]
    - Myasthenia Gravis [C10.668.758.725]

Immune System Diseases [C20]
- Autoimmune Diseases [C20.111]
  - Autoimmune Diseases of the Nervous System [C20.111.258]
    - Myasthenia Gravis [C20.111.258.500]

Immune System Diseases [C20]
- Autoimmune Diseases [C20.111]
  - Autoimmune Diseases of the Nervous System [C20.111.258]
    - Nervous System Autoimmune Disease, Experimental [C20.111.258.625]

Investigative Techniques [E05]
- Models, Animal [E05.598]
  - Disease Models, Animal [E05.598.500]
    - Nervous System Autoimmune Disease, Experimental [E05.598.500.500]

Myasthenia Gravis, Autoimmune, Experimental Preferred

Concept UI: M0328219
Scope Note: Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)
Terms: Myasthenia Gravis, Autoimmune, Experimental Preferred Term
Term UI T573994
Date02/24/2004
LexicalTag NON
ThesaurusID NLM (2005); Myasthenia Gravis, Experimental Autoimmune
Term UI T358219
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000); Myasthenia Gravis, Autoimmune Experimental
Term UI T366672
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000); Autoimmune Experimental Myasthenia Gravis
Term UI T373522
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000); Experimental Myasthenia
Term UI T373524
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000); Experimental Myasthenia Gravis
Term UI T373525
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000)

Experimental Autoimmune Myasthenia Gravis, Passive Transfer Narrower

Myasthenia Gravis, Autoimmune, Experimental MeSH Descriptor Data 2024